Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
BMJ Case Rep ; 12(7)2019 Jul 24.
Article in English | MEDLINE | ID: mdl-31345833

ABSTRACT

We describe an unusual case of a 58-year-old man with type 2 diabetes mellitus (T2DM) developing sepsis secondary to a prevertebral neck abscess. Following cross-sectional imaging, the patient underwent surgical drainage. Salmonella sandiego was isolated from urine, blood and pus cultures. Salmonella species neck infections represent a rare cause of focal salmonellosis, though have been reported in the literature. This is the first reported case of S. sandiego causing neck abscess. The case highlights an atypical presentation of salmonellosis, with the surprising finding of a neck abscess on cross-sectional imaging without evidence of co-existing significant discitis or osteomyelitis.


Subject(s)
Abscess/microbiology , Diabetes Mellitus, Type 2/physiopathology , Neck/microbiology , Salmonella Infections/diagnosis , Salmonella enterica/isolation & purification , Sepsis/diagnosis , Abscess/therapy , Ceftriaxone/therapeutic use , Ciprofloxacin/therapeutic use , Drainage , Humans , Male , Metronidazole/therapeutic use , Middle Aged , Salmonella Infections/drug therapy , Sepsis/complications , Sepsis/therapy , Treatment Outcome
2.
J Antimicrob Chemother ; 71(1): 220-5, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26462990

ABSTRACT

BACKGROUND: Strongyloides stercoralis infection presents with varying degrees of severity, but it often primarily involves the small bowel. In severe infection and cases of hyperinfection, ileus and small-bowel obstruction may prevent enteral absorption of anthelminthics such as ivermectin. At present there are no parenteral anthelminthics licensed for use in humans. METHODS: Here, we describe two cases of severe S. stercoralis infection treated with an unlicensed veterinary preparation of subcutaneous ivermectin, and we discuss the published reports of the use of this treatment elsewhere. RESULTS: Both patients were successfully treated with subcutaneous ivermectin, and both recovered completely. CONCLUSIONS: Despite the limited published experience of parenteral ivermectin use, there is evidence that it may be a safe and effective treatment for severe strongyloidiasis. However, more data are needed to guide dosing schedules and monitoring for toxicity.


Subject(s)
Anthelmintics/administration & dosage , Ivermectin/administration & dosage , Strongyloides stercoralis/drug effects , Strongyloidiasis/drug therapy , Animals , Female , Humans , Injections, Subcutaneous , Male , Middle Aged , Treatment Outcome
3.
JMM Case Rep ; 3(6): e005060, 2016 Dec.
Article in English | MEDLINE | ID: mdl-28348792

ABSTRACT

INTRODUCTION: Myiasis, a term used to describe the infestation of a live animal by fly larvae, is rarely reported in human subjects. The adult fly lays its eggs on living tissue that progresses to become larvae that feed on living tissue having gone through three developmental stages known as the first, second and third instar. The larvae become pupae before finally developing into adults. CASE PRESENTATION: We describe an unusual case of a 79-year-old female who collapsed in her garden and lay there for several days before presenting to her local hospital Accident and Emergency department with an infestation of larvae in her vagina labia, identified as those from the Protophormia species northern blowfly. After complete removal of the larvae using tweezers followed by cleansing of the affected area and a course of antibiotics, the patient's condition improved. A follow-up review by the local gynaecology team revealed no evidence of further infestation. CONCLUSION: It is our understanding that this is the first highly unusual case of a blowfly larvae infestation to be reported in a human within the UK.

5.
Anticancer Res ; 30(2): 339-43, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20332437

ABSTRACT

BACKGROUND: The most common neoplasm arising in the upper gastrointestinal tract is head and neck squamous cell carcinoma (HNSCC). This is an aggressive epithelial malignancy. Many growth factors and cytokines have been discovered that are responsible for the growth and formation of tumours. Among these factors, beta-catenin is considered to be the most important for reducing cell-cell adhesions in malignant tissue. The degradation of beta-catenin triggers apoptosis by different routes. Sulindac sulfone has been shown to induce apoptosis in several different tumours. In the present study, we surveyed the concentration of beta-catenin in an HNSCC line after incubation with different concentrations of sulindac sulfone. MATERIALS AND METHODS: Immunohistochemical and Western blot analyses were performed after treatment of the UMSCC 11A cell line with different concentrations of sulindac sulfone (100, 200, 400, 600 and 800 microMol) for 48 hours. RESULTS: At 100 microMol of sulindac sulfone, a decrease in beta-catenin concentration of 5% was observed; increasing concentrations of sulindac sulfone resulted in >70% reduction in secreted beta-catenin. Thus in conclusion, incubation with sulindac sulfone seemed to stop proliferation. With respect to the controls, there was no greater reduction in total protein. CONCLUSION: In this study, sulindac sulfone reduced levels of secreted beta-catenin in the HNSCC cell line UM-SCC 11A after 48 hours of incubation. It is presumed that reduction of cell-cell adhesion, which is predominately affected by beta-catenin, is an essential step in the progression from localized malignancy to stromal and vascular invasion and ultimately metastatic disease. The reduction in the level of mural expression of beta-catenin has been associated with loss of differentiation in laryngeal carcinomas. Thus, prevention of intracellular beta-catenin accumulation is regarded as an attractive target for chemopreventive agents.


Subject(s)
Antineoplastic Agents/pharmacology , Carcinoma, Squamous Cell/drug therapy , Down-Regulation/drug effects , Head and Neck Neoplasms/drug therapy , Sulindac/analogs & derivatives , beta Catenin/metabolism , Blotting, Western , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Enzyme-Linked Immunosorbent Assay , Head and Neck Neoplasms/metabolism , Head and Neck Neoplasms/pathology , Humans , Immunoenzyme Techniques , Sulindac/pharmacology , Tumor Cells, Cultured
6.
Int J Mol Med ; 22(4): 441-6, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18813849

ABSTRACT

The pathogenesis of eosinophilic chronic rhinosinusitis (ECRS) is still unclear. Paranasal mucosa inflammation is thought to be related to eosinophilic infiltration. This infiltration seems to induce changes in the expression of cell adhesion molecules such as vascular cell adhesion molecule 1 (VCAM-1). The E-cadherin-beta-catenin complex maintains the integrity of the epithelium. Downregulation of beta-catenin and E-cadherin is a pivotal factor for progressive cell growth. This study aimed to assess which cytokines regulate the expression of the adhesion molecule E-cadherin and the multi-functional protein beta-catenin, which plays a key role in cadherin-mediated anchoring in ECRS. Cultured ECRS specimens were incubated with human VCAM-1. After a period of up to 72 h, expression of E-cadherin and beta-catenin was determined using cytokine immunoassay and immunohistochemistry. In ECRS, significant increases in E-cadherin expression were found in fibroblast cell cultures. Stimulation with VCAM-1 did not produce a significant alteration in the expression of the adherens junction protein beta-catenin. In addition, VCAM-1 did not decrease the levels of membrane staining for adherens junction proteins. The selective increase in E-cadherin expression in eosinophilic fibroblast cultures might be explained by a higher concentration of the Th2-type cytokines in these cultures. The tissue remodelling observed during chronic eosinophilic inflammation offers new insight into the pathogenesis of ECRS.


Subject(s)
Eosinophilia/complications , Eosinophilia/pathology , Fibroblasts/drug effects , Fibroblasts/pathology , Sinusitis/complications , Sinusitis/pathology , Vascular Cell Adhesion Molecule-1/pharmacology , Cadherins/metabolism , Cells, Cultured , Chronic Disease , Eosinophilia/metabolism , Fibroblasts/metabolism , Humans , Immunohistochemistry , Sinusitis/metabolism , Time Factors , beta Catenin/metabolism
7.
Oncol Rep ; 19(6): 1373-9, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18497939

ABSTRACT

Increasing incidence of carcinomas in the upper aero-digestive tract, both in Germany and in other European countries requires development of new preventive strategies. The cure rate at advanced tumor stages remains poor in spite of a variety of available therapeutic methods. In the present study the quantitative assessment of a pre-malignant mucosa lesion within a field cancerization was performed by means of immunocytochemical methods. This may allow individuals with an increased risk of developing malignant disease to be identified. Cytosmears taken from healthy buccal mucosa of tumor patients (n=50) and from healthy probands (n=100) with different tobacco and alcohol consumption levels were examined with regard to identifying increased expression of the proliferation markers (PCNA, MIB1), of the tumor suppressor gene product p53 as well as the oncogene product cyclin D1. There was a significant difference in expression of investigated proliferation markers between tumor patients and healthy probands (p<0.0001). When comparing the rate of positively marked cell nuclei to cigarette pack years the marker cyclin D1 and MIB1 show an increased rate in the groups with high tobacco consumption as compared to the group with a low exposure (p>0.05). It could be possible to use the marker MIB1 and cyclin D1 to screen risk groups, since the relative morbidity risk (odds ratio) increases (by 45-62 times) if the threshold value of 4 positively marked cell nuclei is exceeded.


Subject(s)
Biomarkers, Tumor/metabolism , Carcinoma, Squamous Cell/metabolism , Hypopharyngeal Neoplasms/metabolism , Laryngeal Neoplasms/metabolism , Oropharyngeal Neoplasms/metabolism , Precancerous Conditions/metabolism , Carcinoma, Squamous Cell/pathology , Cyclin D , Cyclins/metabolism , Female , Humans , Hypopharyngeal Neoplasms/pathology , Ki-67 Antigen/metabolism , Laryngeal Neoplasms/pathology , Male , Middle Aged , Mouth Mucosa/metabolism , Mouth Mucosa/pathology , Neoplasm Proteins/metabolism , Oropharyngeal Neoplasms/pathology , Precancerous Conditions/pathology , Prognosis , Proliferating Cell Nuclear Antigen/metabolism , Risk Assessment , Tumor Suppressor Protein p53/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...